AstraZeneca withdraws COVID-19 vaccine trials in Philippines
British pharmaceutical firm AstraZeneca has withdrawn its application to conduct Phase 3 clinical trials for its COVID-19 vaccine in the Philippines.
FDA director general Dr. Eric Domingo said AstraZeneca indicated they already have sufficient data on the efficacy of their vaccine.
Despite withdrawing the trial application, AstraZeneca may still supply vaccines to the Philippines once it receives approval from the FDA.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics